Chen Ziwei, Zhang Wenli, Zhang Tao, Jiang Bo, Mu Wanmeng
State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, 214122, China.
Synergetic Innovation Center of Food Safety and Nutrition, Jiangnan University, Wuxi, 214122, China.
Appl Microbiol Biotechnol. 2016 Aug;100(16):6971-9. doi: 10.1007/s00253-016-7694-2. Epub 2016 Jun 25.
Rare sugars have recently drawn attention because of their potential applications and huge market demands in the food and pharmaceutical industries. All L-hexoses are considered rare sugars, as they rarely occur in nature and are thus very expensive. L-Hexoses are important components of biologically relevant compounds as well as being used as precursors for certain pharmaceutical drugs and thus play an important role in the pharmaceutical industry. Many general strategies have been established for the synthesis of L-hexoses; however, the only one used in the biotechnology industry is the Izumoring strategy. In hexose Izumoring, four entrances link the D- to L-enantiomers, ketose 3-epimerases catalyze the C-3 epimerization of L-ketohexoses, and aldose isomerases catalyze the specific bioconversion of L-ketohexoses and the corresponding L-aldohexoses. In this article, recent studies on the enzymatic production of various L-hexoses are reviewed based on the Izumoring strategy.
稀有糖因其在食品和制药行业的潜在应用和巨大市场需求,近年来受到了关注。所有的L-己糖都被视为稀有糖,因为它们在自然界中很少出现,因此非常昂贵。L-己糖是生物相关化合物的重要组成部分,同时也被用作某些药物的前体,因此在制药行业中发挥着重要作用。已经建立了许多合成L-己糖的通用策略;然而,生物技术行业中唯一使用的是“和糖法”策略。在己糖和糖法中,有四个入口将D-对映体与L-对映体连接起来,酮糖3-表异构酶催化L-酮己糖的C-3表异构化,醛糖异构酶催化L-酮己糖和相应的L-醛己糖的特定生物转化。在本文中,基于和糖法策略,对各种L-己糖的酶促生产的最新研究进行了综述。